| Advisory Board |
| Tom Aelbrecht |
: Head of Janssen Campus Office, Janssen Pharmaceutica |
| Harrold van Barlingen |
: Partner, Thuja Capital |
| Patrick Van Beneden |
: Partner, Gimv and Board Member FlandersBio |
| Gil Beyen |
: Chairman & CEO Erytech Pharma |
| Jérôme van Biervliet |
: Senior Business Development Manager, VIB |
| prof. dr. Clemens van Blitterswijk |
: Founding partner of LSP Health Economics Fund (LSP HEF);Professor of tissue engineering,University of Maastricht |
| Erwin Blomsma |
: CEO and co-founder at ViroVet and Chairman of the board of FlandersBio |
| Jo De Boeck |
: CTO and Senior VP, IMEC and Board Member FlandersBio |
| Ronald Brus |
: Founding CEO at MyTomorrows |
| dr. Hanno Cappon |
: VP R&D Nutricia Medical Nutrition |
| Johan Cardoen |
: Managing Director VIB, Board Member FlandersBIO |
| Koenraad Debackere |
: General Manager KU Leuven - Research & Development |
| Rudy Dekeyser |
: Managing Partner LSP Health Economics Fund |
| Janke Dittmer |
: Partner Gilde Healthcare |
| Joep de Groot |
: Board Member CbusineZ, Board of Directors CZ |
| dr. Patrik de Haes |
: CEO ThromboGenics |
| Jeremy Halpern |
: Partner and Director of Business Development, Nutter, McClennen & Fish LLP |
| Hans Hofstraat |
: Vice President Philips Research |
| Cees de Jong |
: CEO Chr. Hansen A/S |
| Henk Joos |
: Managing Director FlandersBio |
| Ludo Lauwers |
: Experienced Pharmaceutical Executive, former Senior Vice President at Janssen Pharmaceutica |
| dr. Ton Logtenberg |
: CEO Merus |
| Rudi Mariën |
: Managing Director Biovest |
| Dirkjan Masman |
: Director Technology Transfer Office Radboudumc |
prof. dr. Nico van Meeteren
prof. dr. Frank Miedema |
: Executive Director Topsector LSH, Professor Physiotherapy Functioning in Chronicity
: Dean Faculty of Medicine, Vice Chairman UMC Utrecht |
dr. Edwin Moses
dr. Freek van Muiswinkel
Geert-Jan Mulder |
: CEO Ablynx
: Managing Director Utrecht Life Sciences
: General Partner Forbion Capital Partner |
| Leo Neels |
: Chairman of the Advisory Board of Vlerick Healthcare Management Centre, former CEO pharma.be |
| dr. Arno Nierich |
: Anesthesiologist-Intensivist, Head Innovation Isala Clinics |
| dr. Rudi Pauwels |
: CEO, Director Biocartis |
| René Penning de Vries |
: Innovation Manager and Chairman Health Valley Netherlands |
| prof. dr. Anton Pijpers |
: Vice-chairman Board of Utrecht University |
| Rob de Ree |
: CEO Dezima Pharma |
| Dirk Reyn |
: CEO eTheRNA, CEO Progress Pharma and Vice Chairman of the board of FlandersBio |
| Pieter Rhemrev |
: PPM Oost NV, Life Sciences & Health |
| Michel van Schaik |
: Director Healtcare Rabobank |
| Albert Scherpbier |
: Dean Faculty of Health, Medicine and Life Sciences, Maastricht University |
| Oscar Schoots |
: Director UU Holding BV/UMC Utrecht Holding BV |
| Paul Smits |
: Dean and Vice Chairman Executive Board Radboudumc |
| Dominic Spadafore |
: Principal at Dominic Spadafore and Associates LLC |
| prof. dr. Marianne van der Steen |
: Founder MBI Life Sciences & Health |
| Onno van de Stolpe |
: CEO at Galapagos NV |
| Henri Termeer |
: Former CEO Genzyme Corporation |
| Mark Vaeck |
: CEO Complix |
| Susan Windham-Bannister |
: Founding CEO of the Massachusetts Life Sciences Center |
| Pieter Wolters |
: Managing Director Venturing and Licensing DSM |
| Chantal van der Zwan |
: Investment Director, NextStage Investments |